GLP-1 & Metabolic Health

Last updated
Jul 20, 2026
Based on
226 actions
Gurus considered
148
Stocks covered
170

Obesity, diabetes, GLP-1, and metabolic disease exposure. This page tracks 226 investor, Congress, and insider actions tied to GLP-1 & Metabolic Health within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 148 gurus across 170 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.

GLP-1 & Metabolic Health Smart Money Notes

Ball Titus B.PAO

Sell $30.9K of disclosed value in BeOne Medicines Ltd. $ONC.

Sell

Jefferies Group

Trim $-340.6M of disclosed value in Eli Lilly and Co $LLY.

Trim

Tom GaynerMarkel

Trim $105.5M of disclosed value in Novo Nordisk A/S $NVO.

Trim

Sands Capital

Exit $-301.6M of disclosed value in iRhythm Technologies, Inc. $IRTC.

Exit

Tweedy Browne

Add $10.9M of disclosed value in Novartis AG Common Stock $NVS.

Add

Jefferies Group

Add $28.7M of disclosed value in PTC THERAPEUTICS, INC. $PTCT.

Add
Showing 211-226 of 226